Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer

Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer

Previous studies have demonstrated that redox selenium compounds arrest cancer cell viability in vitro through their pro-oxidative activity by generating superoxide (O<sub>2</sub><sup>•−</sup>). Currently, there are no efficacious treatment options for wom...

Full description

Bibliographic Details
Main Authors:	Soni Khandelwal, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz, Lauren S. Gollahon
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Antioxidants
Subjects:	selenofolate folic acid selenium superoxide tnbc cells mda-mb-468 cells mammary epithelial cells hme50-5e cells targeted cancer therapy
Online Access:	https://www.mdpi.com/2076-3921/9/2/138

Similar Items

Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells
by: Soni Khandelwal, et al.
Published: (2018-10-01)

The Cytotoxicity Effect of Extracted Pigment from Haloarcula sp. on MDA-MB-468 Breast Cancer Cell Line
by: Saghar Shahbazi, et al.
Published: (2022-11-01)

Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells
by: Samia S. Messeha, et al.
Published: (2020-12-01)

Apoptotic Effect of the Urtica Dioica Plant Extracts on Breast Cancer Cell Line (MDA- MB- 468)
by: A Mohammadi, et al.
Published: (2015-09-01)

An Evaluation of the Anticancer Properties of SYA014, a Homopiperazine-Oxime Analog of Haloperidol in Triple Negative Breast Cancer Cells
by: Gladys M. Asong, et al.
Published: (2022-12-01)

Development of two stable green nanoformulations with potent anticancer properties
by: Ali Ghanbariasad, et al.
Published: (2020-09-01)

Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
by: Abdullah Alsrhani, et al.
Published: (2023-04-01)

The Effect of Pomegranate Seed Oil on the Proliferation of Human Breast Cancer Cell Lines MCF-7 and MDA-MB468
by: Mahsa Servatkhah, et al.
Published: (2015-02-01)

Investigation of Antioxidant and Cytotoxicity Activities of Chocolate Fortified with Muscadine Grape Pomace
by: Ahmed G. Darwish, et al.
Published: (2023-08-01)

Monomethyl Auristatin E, a Potent Cytotoxic Payload for Development of Antibody-Drug Conjugates against Breast Cancer
by: Meghdad Abdollahpour-alitappeh, et al.
Published: (2017-06-01)

Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha
by: Ali Razaghi, et al.
Published: (2021-06-01)

Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells
by: Samia S. Messeha, et al.
Published: (2022-07-01)

Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells
by: Ana Paço, et al.
Published: (2021-10-01)

Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis
by: Jensen M. Spear, et al.
Published: (2020-12-01)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
by: Kristijan Skok, et al.
Published: (2021-12-01)

The Selenium Yeast vs Selenium Methionine on Cell Viability, Selenoprotein Profile and Redox Status via JNK/ P38 Pathway in Porcine Mammary Epithelial Cells
by: Caichi Wu, et al.
Published: (2022-04-01)

Calyculin A from Discodermia Calyx Is a Dual Action Toxin that Blocks Calcium Influx and Inhibits Protein Ser/Thr Phosphatases
by: David L. Brautigan, et al.
Published: (2012-10-01)

Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells
by: Jinyan Shen, et al.
Published: (2020-04-01)

Expression of SR-B1 receptor in breast cancer cell lines, MDA-MB-468 and MCF-7: Effect on cell proliferation and apoptosis
by: Neamat Karimi, et al.
Published: (2021-08-01)

Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
by: Neelam Mishra, et al.
Published: (2021-11-01)

In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids
by: Vera M. S. Isca, et al.
Published: (2020-09-01)

GC, GC/MS Analysis, and Biological Effects of Essential Oils from <i>Thymus mastchina</i> and <i>Elettaria cardamomum</i>
by: Nenad L. Vukovic, et al.
Published: (2022-11-01)

Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2
by: Wu Xiaojing, et al.
Published: (2012-05-01)

Dysregulated Gab1 signalling in triple negative breast cancer
by: Hannes Bongartz, et al.
Published: (2024-03-01)

Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
by: Fateme Shafiee, et al.
Published: (2012-01-01)

A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK–STAT3 Signaling
by: Hyeri Jang, et al.
Published: (2019-07-01)

Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
by: Wojciech Wojtowicz, et al.
Published: (2020-04-01)

Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
by: Bo Yuan, et al.
Published: (2018-08-01)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2019-02-01)

Computational pharmacokinetic analysis on some newly designed 2-anilinopyrimidine derivative compounds as anti-triple-negative breast cancer drug compounds
by: Hadiza Lawal Abdulrahman, et al.
Published: (2020-04-01)

Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells
by: Natalia Lemos Chaves, et al.
Published: (2019-09-01)

Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
by: Vanessa Klapp, et al.
Published: (2023-02-01)

Zinc oxide-manganese oxide/carboxymethyl cellulose-folic acid-sesamol hybrid nanomaterials: A molecularly targeted strategy for advanced triple-negative breast cancer therapy
by: Zhao Chunming, et al.
Published: (2024-02-01)

The selenium cell : its properties and applications/
by: 263920 Barnard, George P.
Published: (1930)

Effects of rotary cell culture system‐simulated microgravity on the ultrastructure and biological behavior of human MDA‐MB‐231 breast cancer cells
by: Nan Jiang, et al.
Published: (2019-09-01)

Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells
by: Basant Emad, et al.
Published: (2023-11-01)

Zein - laponite coacervate aided co-delivery of curcumin and cisplatin towards MDA-MB-231 breast cancer cells: Validating the concept
by: Preeti Tiwari, et al.
Published: (2023-12-01)

HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype
by: Simone Aparecida de Bessa Garcia, et al.
Published: (2021-05-01)

Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells
by: Nam-Hoon Kim, et al.
Published: (2013-01-01)

Small RNA sequencing reveals a novel tsRNA-26576 mediating tumorigenesis of breast cancer
by: Zhou J, et al.
Published: (2019-05-01)